FDA Approved: AUBAGIO — Original Application (Genzyme Corporation)

View source ↗

Summary

FDA approved Aubagio (teriflunomide) from Genzyme in its original application for the treatment of relapsing forms of multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• AUBAGIO (TERIFLUNOMIDE)

Snippet

ORIG AP for AUBAGIO (TERIFLUNOMIDE)